Vaccinex (NASDAQ:VCNX) Stock Price Down 3.7% – Time to Sell?

Vaccinex, Inc. (NASDAQ:VCNX)’s stock price traded down 3.7% on Wednesday . The company traded as low as $1.02 and last traded at $1.03. 2,424 shares changed hands during trading, a decline of 34% from the average session volume of 3,651 shares. The stock had previously closed at $1.07.

Vaccinex Trading Down 3.7 %

The stock has a market cap of $2.68 million, a price-to-earnings ratio of -0.02 and a beta of 1.10. The stock’s 50 day moving average is $1.26 and its two-hundred day moving average is $3.04.

Institutional Trading of Vaccinex

An institutional investor recently raised its position in Vaccinex stock. Point72 Asset Management L.P. grew its position in shares of Vaccinex, Inc. (NASDAQ:VCNX) by 42.4% in the third quarter, according to the company in its most recent 13F filing with the SEC. The fund owned 166,000 shares of the company’s stock after buying an additional 49,454 shares during the quarter. Point72 Asset Management L.P. owned 9.60% of Vaccinex worth $564,000 as of its most recent filing with the SEC. 50.11% of the stock is owned by institutional investors.

Vaccinex Company Profile

Vaccinex, Inc, a clinical-stage biotechnology company, engages in the discovery and development of targeted biotherapeutics to treat cancer, neurodegenerative diseases, and autoimmune disorders. The company's lead drug candidate, pepinemab, a humanized monoclonal antibody that binds and blocks the activity of SEMA4D.